http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101064848-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-33 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-48 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-48 |
filingDate | 2008-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2011-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2011-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101064848-B1 |
titleOfInvention | Extract of mimosa for allergy treatment and pharmaceutical composition for allergy comprising the same as an active ingredient |
abstract | The present invention relates to a mimosa extract and a pharmaceutical composition for treating allergies comprising the same as an active ingredient, in order to confirm the usefulness of the extract of the mimosa (1) extracts of mimosa for jujutsu movement of mast cells by stem cell factor Effect, (2) toxic effect of mimosa extract on cells, (3) inflammatory cytokines and chemokines, MCP-1 (monocyte chemoattractant protein-1) and IL-6 in human eosinophilic leukemic cells The inhibitory effect of mimosa extract on (Interleukin-6) and (4) the effects of mimosa extract on asthma-induced mice were confirmed, and it can be confirmed that it can be effectively used for improving or treating atopy and / or asma. there was.n n n n Atopy, Asma, Mimosa, Chemokine, Interleukin, Mast Cell |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017216274-A2 |
priorityDate | 2008-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 200.